510(k) K925110

ABBOTT IMX T4 by Abbott Laboratories — Product Code CDX

K925110 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "ABBOTT IMX T4". The FDA issued a decision of Substantially Equivalent on January 26, 1993. The device falls under product code CDX (Radioimmunoassay, Total Thyroxine), a Class II device regulated under 21 CFR 862.1700. Abbott Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 26, 1993
Date Received
October 9, 1992
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Radioimmunoassay, Total Thyroxine
Device Class
Class II
Regulation Number
862.1700
Review Panel
CH
Submission Type